JMP Securities Reiterates Market Outperform on MorphoSys, Maintains $15 Price Target
Portfolio Pulse from richadhand@benzinga.com
JMP Securities analyst Jason Butler reiterates a Market Outperform rating on MorphoSys (NASDAQ:MOR) and maintains a $15 price target.
June 22, 2023 | 2:51 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
JMP Securities reiterates a Market Outperform rating on MorphoSys and maintains a $15 price target.
The reiterated Market Outperform rating and maintained $15 price target by JMP Securities analyst Jason Butler indicates a positive outlook for MorphoSys in the short term. This news is likely to boost investor confidence and potentially drive the stock price up.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100